DBT-BIRAC supported startup Blackfrog Technologies has developed Emvolio, a portable, battery-powered medical-grade refrigeration device that improves the efficiency of the immunization.
Context
DBT-BIRAC supported startup Blackfrog Technologies has developed Emvolio, a portable, battery-powered medical-grade refrigeration device that improves the efficiency of the immunization.
What is Emvolio?
- Emvo?lio has a 2-litre capacity, enabling it to carry 30-50 vials, the standard for a daylong immunization campaign.
- The device also includes continuous temperature monitoring, location tracking, state-of-charge indication, communication with headquarters via live-tracking, and vital statistics for improved coverage.
- Blackfrog is an ISO-13485 certified manufacturer of medical devices, and Emvólio has been designed in accordance with WHO-PQS E003 standards.
- Emvo?lio’s patented technology ensures that all contents in the cold chamber are blanketed in strictly temperature-controlled air.
- The underlying refrigeration mechanism is solid-state cooling with a smart PID (Proportional Integral Derivate) controller, which guarantees precise temperature maintenance without the risk of noxious refrigerant leakage or cross-contamination.
- The lack of motors/compressors or any moving parts enables low-maintenance operation.
- The unique design of Emvo?lio promises uniform cooling and minimal freeze-thaw cycles.
- This startup has received grants from BIRAC under SEED fund, BIG for the development of proof-of-concept, BIPP for developing an end-to-end vaccine traceability system and has also been supported through BioNEST incubators.
Significance of the device
- Due to its ability of the device to strictly maintain the temperature between 2°C and 8°C for up to 12 hours in the field, the device is being used as a platform for delivery of vaccines and all other biologicals like blood, serums, viral culture.
